Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Biochem Pharmacol. 2010 May 10;80(5):654–665. doi: 10.1016/j.bcp.2010.04.035

Fig. 4.

Fig. 4

Therapeutic targeting of glioma stem cells (GSCs) and non-stem cancer cells (Non-GSCs). Targeting both populations of glioblastoma cancer cells is important to eliminate the tumor, since non-stem cancer cells may be able to reprogram into GSCs under certain conditions.